Twelve-month Outcomes After Coronary Stenting With the Genous™ Bio-Engineered R Stent™ in Diabetic Patients from the e-HEALING Registry

Abstract

The 1-year results of the Genous stent in a real-world population of diabetics show higher TVF rates in diabetics compared with nondiabetics, mainly driven by a higher mortality hazard. IRD is associated with a significant higher TLR hazard. Definite or probable ST in all diabetic patients was comparable with nondiabetics. (J Interven Cardiol 2011;24:285-294).